Skip to main content
Top
Published in: Molecular Imaging and Biology 3/2011

01-06-2011 | Research Article

Clinical Utility of Positron Emission Tomography/Computed Tomography in Inflammatory Bowel Disease

Authors: Robert T. Lapp, Bret J. Spier, Scott B. Perlman, Christine J. Jaskowiak, Mark Reichelderfer

Published in: Molecular Imaging and Biology | Issue 3/2011

Login to get access

Abstract

Purpose

The clinical utility of positron emission tomography/computed tomography (PET/CT) in comparison to standard workup in patients with known or suspected inflammatory bowel disease (IBD) is unknown.

Procedures

Clinical data were collected on seven patients with known or suspected IBD undergoing PET/CT. Standard workup included history, physical exam, laboratory tests, colonoscopy and/or cross-sectional imaging. We divided the intestine into five regions [small bowel and four colon (ascending, transverse, descending and rectosigmoid)] and graded relative standard uptake values 0, 1, 2 or 3 by comparison to the liver, using a region-of-interest analysis (0 = no activity, 1 = liver, 2 and 3 = significant inflammation).

Results

In patients 1 and 2, PET/CT demonstrated more activity than we thought clinically present. The other patients avoided unnecessary escalation or initiation of IBD therapy based on PET/CT results. Compared with standard workup, all seven patients had superior results when therapeutic decisions were based on PET/CT.

Conclusions

We found PET/CT to be very useful in diagnosis and management in patients with known or suspected IBD.
Literature
1.
go back to reference Xavier RJ, Podolsky DK (2007) Unraveling the pathogenesis of inflammatory bowel disease. Nature 448:427–434PubMedCrossRef Xavier RJ, Podolsky DK (2007) Unraveling the pathogenesis of inflammatory bowel disease. Nature 448:427–434PubMedCrossRef
3.
go back to reference Bernstein CN, Fried M, Krabshuis JH et al (2010) World gastroenterology organization practice guidelines for the diagnosis and management of IBD in 2010. Inflamm Bowel Dis 16:112–124PubMed Bernstein CN, Fried M, Krabshuis JH et al (2010) World gastroenterology organization practice guidelines for the diagnosis and management of IBD in 2010. Inflamm Bowel Dis 16:112–124PubMed
4.
go back to reference Spier BJ, Perlman SB, Reichelderfer MX (2009) FDG-PET in inflammatory bowel disease. QJ Nucl Med Mol Imaging 53:64–71 Spier BJ, Perlman SB, Reichelderfer MX (2009) FDG-PET in inflammatory bowel disease. QJ Nucl Med Mol Imaging 53:64–71
5.
go back to reference Bick I, Bauerfeind P, BreitBach T et al (1997) Inflammatory bowel disease activity measured by positron-emission tomography. Lancet 350:262CrossRef Bick I, Bauerfeind P, BreitBach T et al (1997) Inflammatory bowel disease activity measured by positron-emission tomography. Lancet 350:262CrossRef
6.
go back to reference Lemberg DA, Issenman RM, Cawdron R et al (2005) Positron emission tomography in the investigation of pediatric inflammatory bowel disease. Inflamm Bowel Dis 11:733–738PubMedCrossRef Lemberg DA, Issenman RM, Cawdron R et al (2005) Positron emission tomography in the investigation of pediatric inflammatory bowel disease. Inflamm Bowel Dis 11:733–738PubMedCrossRef
7.
go back to reference Loffler M, Weckesser M, Franzius C et al (2006) High diagnostic value of 18F-FDG-PET in pediatric patients with chronic inflammatory bowel disease. Ann N Y Acad Sci 1072:379–385PubMedCrossRef Loffler M, Weckesser M, Franzius C et al (2006) High diagnostic value of 18F-FDG-PET in pediatric patients with chronic inflammatory bowel disease. Ann N Y Acad Sci 1072:379–385PubMedCrossRef
8.
go back to reference Neurath MF, Vehling D, Schunk K et al (2002) Noninvasive assessment of Crohn's disease activity: a comparison of 18F-fluorodeoxyglucose positron emission tomography, hydromagnetic resonance imaging, and granulocyte scintigraphy with labeled antibodies. Am J Gastroenterol 97:1978–1985PubMedCrossRef Neurath MF, Vehling D, Schunk K et al (2002) Noninvasive assessment of Crohn's disease activity: a comparison of 18F-fluorodeoxyglucose positron emission tomography, hydromagnetic resonance imaging, and granulocyte scintigraphy with labeled antibodies. Am J Gastroenterol 97:1978–1985PubMedCrossRef
9.
go back to reference Adler J, Stidham RW, Higgins PDR (2009) Bringing the inflamed and fibrotic bowel into focus: imaging in inflammatory bowel disease. Gastroenterology & Hepatology 5:705–715 Adler J, Stidham RW, Higgins PDR (2009) Bringing the inflamed and fibrotic bowel into focus: imaging in inflammatory bowel disease. Gastroenterology & Hepatology 5:705–715
10.
go back to reference Louis E, G. Ancion A, Colard V et al (2007) Noninvasive assessment of Crohn's disease intestinal lesions with (18)F-FDG PET/CT. J Nucl Med 48:1053–1059, Louis E, G. Ancion A, Colard V et al (2007) Noninvasive assessment of Crohn's disease intestinal lesions with (18)F-FDG PET/CT. J Nucl Med 48:1053–1059,
11.
go back to reference Meisner, Randall S, Bret J Spier, Sigurdur Einarsson et al (2007) Pilot study using PET/CT as a novel, noninvasive assessment of disease activity in inflammatory bowel disease. Inflammatory Bowel Disease 13:993–1000 Meisner, Randall S, Bret J Spier, Sigurdur Einarsson et al (2007) Pilot study using PET/CT as a novel, noninvasive assessment of disease activity in inflammatory bowel disease. Inflammatory Bowel Disease 13:993–1000
12.
go back to reference Spier BJ, Perlman SB, Jaskowiak CJ et al (2009) PET/CT in the evaluation of inflammatory bowel disease: studies in patients before and after treatment. Molecular Imaging and Biology Spier BJ, Perlman SB, Jaskowiak CJ et al (2009) PET/CT in the evaluation of inflammatory bowel disease: studies in patients before and after treatment. Molecular Imaging and Biology
14.
go back to reference Sandborn WJ, Tremaine WJ, Batts KP et al (1994) Pouchitis after ileal pouch-anal anastomosis: a pouchitis disease activity index. Mayo Clin Proc 69:409–415PubMed Sandborn WJ, Tremaine WJ, Batts KP et al (1994) Pouchitis after ileal pouch-anal anastomosis: a pouchitis disease activity index. Mayo Clin Proc 69:409–415PubMed
Metadata
Title
Clinical Utility of Positron Emission Tomography/Computed Tomography in Inflammatory Bowel Disease
Authors
Robert T. Lapp
Bret J. Spier
Scott B. Perlman
Christine J. Jaskowiak
Mark Reichelderfer
Publication date
01-06-2011
Publisher
Springer-Verlag
Published in
Molecular Imaging and Biology / Issue 3/2011
Print ISSN: 1536-1632
Electronic ISSN: 1860-2002
DOI
https://doi.org/10.1007/s11307-010-0367-0

Other articles of this Issue 3/2011

Molecular Imaging and Biology 3/2011 Go to the issue